Literature DB >> 25630911

Measuring quality of life in children with speech and language difficulties: a systematic review of existing approaches.

Tim Gomersall1, Sarah Spencer2, Hasan Basarir1, Aki Tsuchiya1,3, Judy Clegg2, Anthea Sutton1, Kath Dickinson1.   

Abstract

BACKGROUND: Children's and adolescent's speech and language difficulties (SaLD) can affect various domains of quality of life (QoL), and speech and language therapy interventions are critical to improving QoL. Systematically measuring QoL outcomes in this population is highly complex due to factors such as heterogeneity in impairments and differing targets during intervention. However, measurements of QoL are increasingly required by healthcare commissioners and policy-makers to inform resource allocation. AIMS: To review the use of QoL measures in research involving children (age ≤ 18 years) with SaLD. METHODS & PROCEDURES: A systematic review was undertaken. A systematic search across various databases was performed. Information on the methodological details of each relevant study, along with descriptions of the QoL measures employed, were extracted into standardized data extraction forms. Findings were discussed in a narrative synthesis. OUTCOMES &
RESULTS: Twenty-one relevant studies were identified that deal with a range of subpopulations of children with SaLD. For the most part, generic QoL measures were used, although there was little convergence on the type of QoL measures employed throughout the literature. Five studies utilized preference-based QoL measures, including the 16D/17D, HUI3, EQ-5D and QWB-SA. Of these measures, the HUI3 demonstrated the most promising discriminant validity, although the preference weights for this measure were generated with adults. CONCLUSIONS & IMPLICATIONS: QoL among children with SaLD is not yet being captured in a systematic way. The HUI3 measure appears to show some promise for generating relevant preference-based QoL estimates, although further testing of the measure is required.
© 2015 Royal College of Speech and Language Therapists.

Entities:  

Keywords:  outcome; paediatric; quality of life; speech and language difficulties; systematic review

Mesh:

Year:  2015        PMID: 25630911     DOI: 10.1111/1460-6984.12147

Source DB:  PubMed          Journal:  Int J Lang Commun Disord        ISSN: 1368-2822            Impact factor:   3.020


  5 in total

1.  Brazilian-Portuguese Linguistic Validation of the Velopharyngeal Insufficiency Effects on Life Outcome Instrument.

Authors:  Rafael Denadai; Cassio Eduardo Raposo-Amaral; Anelise Sabbag; Rafael Andrade Ribeiro; Celso Luiz Buzzo; Cesar Augusto Raposo-Amaral; Man Hung; Jonathan R Skirko
Journal:  J Craniofac Surg       Date:  2019 Nov-Dec       Impact factor: 1.046

2.  The comparison of perceived health-related quality of life between Australian children with severe specific language impairment to age and gender-matched peers.

Authors:  Kristy Nicola; Pauline Watter
Journal:  BMC Pediatr       Date:  2018-02-14       Impact factor: 2.125

Review 3.  Assessing quality of life in psychosocial and mental health disorders in children: a comprehensive overview and appraisal of generic health related quality of life measures.

Authors:  Jochen O Mierau; Daphne Kann-Weedage; Pieter J Hoekstra; Lisan Spiegelaar; Danielle E M C Jansen; Karin M Vermeulen; Sijmen A Reijneveld; Barbara J van den Hoofdakker; Erik Buskens; M Elske van den Akker-van Marle; Carmen D Dirksen; Annabeth P Groenman
Journal:  BMC Pediatr       Date:  2020-07-03       Impact factor: 2.125

Review 4.  Consequential differences in perspectives and practices concerning children with developmental language disorders: an integrative review.

Authors:  Aoife L Gallagher; Carol-Anne Murphy; Paul Conway; Alison Perry
Journal:  Int J Lang Commun Disord       Date:  2019-04-04       Impact factor: 3.020

5.  Health-related quality of life from the perspective of children with severe specific language impairment.

Authors:  Kristy Nicola; Pauline Watter
Journal:  Health Qual Life Outcomes       Date:  2015-08-14       Impact factor: 3.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.